Phyllis G. Spivack

Array ( [id] => 6401458 [patent_doc_number] => 20100305077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'COMPOUNDS FOR THE SELECTIVE TREATMENT OF THE INTESTINAL IMMUNO-INFLAMMATORY COMPONENT OF THE CELIAC DISEASE' [patent_app_type] => utility [patent_app_number] => 12/810159 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8194 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305077.pdf [firstpage_image] =>[orig_patent_app_number] => 12810159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552837 [patent_doc_number] => 20090286823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'CCR1 Inhibitors useful for the treatment of multiple myeloma and other disorders' [patent_app_type] => utility [patent_app_number] => 12/316901 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14879 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286823.pdf [firstpage_image] =>[orig_patent_app_number] => 12316901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4570271 [patent_doc_number] => 07858612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Therapeutic agent for inflammatory bowel diseases' [patent_app_type] => utility [patent_app_number] => 12/449371 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 7785 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858612.pdf [firstpage_image] =>[orig_patent_app_number] => 12449371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374798 [patent_doc_number] => 20090312359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'USE OF METHYLNALTREXONE AND RELATED COMPOUNDS FOR TREATMENT OF GASTROINTESTINAL DYSFUNCTION INDUCED BY ENDOGENOUS OPIOIDS' [patent_app_type] => utility [patent_app_number] => 12/333912 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3544 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312359.pdf [firstpage_image] =>[orig_patent_app_number] => 12333912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774439 [patent_doc_number] => 08119656 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Inhibitors of the influenza virus non-structural 1 protein' [patent_app_type] => utility [patent_app_number] => 12/315945 [patent_app_country] => US [patent_app_date] => 2008-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 14835 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119656.pdf [firstpage_image] =>[orig_patent_app_number] => 12315945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196985 [patent_doc_number] => 07638552 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-12-29 [patent_title] => 'Method for increasing the bioavailability of glycopyrrolate' [patent_app_type] => utility [patent_app_number] => 12/325755 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7619 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638552.pdf [firstpage_image] =>[orig_patent_app_number] => 12325755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687494 [patent_doc_number] => 20090176797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING ESOPHAGEAL CANCER' [patent_app_type] => utility [patent_app_number] => 12/315291 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13771 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176797.pdf [firstpage_image] =>[orig_patent_app_number] => 12315291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575977 [patent_doc_number] => 20090143339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'METHODS USING PHOSPHATIDYLSERINE, LYSOPHOSPHATIDYLSERINE, AND/OR SALTS THEREOF TO INCREASE TESTOSTERONE LEVELS' [patent_app_type] => utility [patent_app_number] => 12/325225 [patent_app_country] => US [patent_app_date] => 2008-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6120 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143339.pdf [firstpage_image] =>[orig_patent_app_number] => 12325225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391640 [patent_doc_number] => 20090208953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'NEUROFIBROMIN PATHWAY MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/269681 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11092 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208953.pdf [firstpage_image] =>[orig_patent_app_number] => 12269681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392187 [patent_doc_number] => 20090209500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'USE OF VITAMIN D RECEPTOR AGONISTS AND PRECURSORS TO TREAT FIBROSIS' [patent_app_type] => utility [patent_app_number] => 12/266513 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32078 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209500.pdf [firstpage_image] =>[orig_patent_app_number] => 12266513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476129 [patent_doc_number] => 20100284993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Enhancing the Efficacy of Anti-Infective Therapeutics' [patent_app_type] => utility [patent_app_number] => 12/739390 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8824 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284993.pdf [firstpage_image] =>[orig_patent_app_number] => 12739390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436303 [patent_doc_number] => 20090170890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'METHOHDS OF INHIBITING VIRAL INFECTION' [patent_app_type] => utility [patent_app_number] => 12/256571 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 73 [patent_figures_cnt] => 73 [patent_no_of_words] => 17993 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170890.pdf [firstpage_image] =>[orig_patent_app_number] => 12256571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5417048 [patent_doc_number] => 20090042935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'NOVEL IV FORMULATION OF TIPIFARNIB' [patent_app_type] => utility [patent_app_number] => 12/253799 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7709 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042935.pdf [firstpage_image] =>[orig_patent_app_number] => 12253799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285537 [patent_doc_number] => 20090099212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'A3 ADENOSINE RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/253019 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15385 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099212.pdf [firstpage_image] =>[orig_patent_app_number] => 12253019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527479 [patent_doc_number] => 08044071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Method for reducing side effects of CB2 receptor agonist therapy using a combination of a selective CB2 receptor agonist and a selective CB1 receptor antagonist' [patent_app_type] => utility [patent_app_number] => 12/252811 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10200 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044071.pdf [firstpage_image] =>[orig_patent_app_number] => 12252811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201131 [patent_doc_number] => 08188105 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient' [patent_app_type] => utility [patent_app_number] => 12/682599 [patent_app_country] => US [patent_app_date] => 2008-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5193 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188105.pdf [firstpage_image] =>[orig_patent_app_number] => 12682599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354670 [patent_doc_number] => 20090186014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'METHOD FOR TREATMENT OF PANCREATITIS' [patent_app_type] => utility [patent_app_number] => 12/248259 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16806 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186014.pdf [firstpage_image] =>[orig_patent_app_number] => 12248259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33695 [patent_doc_number] => 07786169 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Phenoxyalkycarboxylic acid derivatives in the treatment of ulcerative colitis' [patent_app_type] => utility [patent_app_number] => 12/240678 [patent_app_country] => US [patent_app_date] => 2008-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 15 [patent_no_of_words] => 6559 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/786/07786169.pdf [firstpage_image] =>[orig_patent_app_number] => 12240678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509263 [patent_doc_number] => 20090082470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'STAT3 INHIBITING COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/236749 [patent_app_country] => US [patent_app_date] => 2008-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10722 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082470.pdf [firstpage_image] =>[orig_patent_app_number] => 12236749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441876 [patent_doc_number] => 20090093515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Substituted pyrroline kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/284452 [patent_app_country] => US [patent_app_date] => 2008-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17215 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093515.pdf [firstpage_image] =>[orig_patent_app_number] => 12284452 [rel_patent_id] =>[rel_patent_doc_number] =>)